27630165|t|Long-Lived CD4+IFN-g+ T Cells rather than Short-Lived CD4+IFN-g+IL-10+ T Cells Initiate Rapid IL-10 Production To Suppress Anamnestic T Cell Responses during Secondary Malaria Infection.
27630165|a|CD4(+) T cells that produce IFN-g are the source of host-protective IL-10 during primary infection with a number of different pathogens, including Plasmodium spp. The fate of these CD4(+)IFN-g(+)IL-10(+) T cells following clearance of primary infection and their subsequent influence on the course of repeated infections is, however, presently unknown. In this study, utilizing IFN-g-yellow fluorescent protein (YFP) and IL-10-GFP dual reporter mice, we show that primary malaria infection-induced CD4(+)YFP(+)GFP(+) T cells have limited memory potential, do not stably express IL-10, and are disproportionately lost from the Ag-experienced CD4(+) T cell memory population during the maintenance phase postinfection. CD4(+)YFP(+)GFP(+) T cells generally exhibited a short-lived effector rather than effector memory T cell phenotype postinfection and expressed high levels of PD-1, Lag-3, and TIGIT, indicative of cellular exhaustion. Consistently, the surviving CD4(+)YFP(+)GFP(+) T cell-derived cells were unresponsive and failed to proliferate during the early phase of secondary infection. In contrast, CD4(+)YFP(+)GFP(-) T cell-derived cells expanded rapidly and upregulated IL-10 expression during secondary infection. Correspondingly, CD4(+) T cells were the major producers within an accelerated and amplified IL-10 response during the early stage of secondary malaria infection. Notably, IL-10 exerted quantitatively stronger regulatory effects on innate and CD4(+) T cell responses during primary and secondary infections, respectively. The results in this study significantly improve our understanding of the durability of IL-10-producing CD4(+) T cells postinfection and provide information on how IL-10 may contribute to optimized parasite control and prevention of immune-mediated pathology during repeated malaria infections.
27630165	11	14	CD4	GeneOrGeneProduct	12504
27630165	15	20	IFN-g	GeneOrGeneProduct	15978
27630165	54	57	CD4	GeneOrGeneProduct	12504
27630165	58	63	IFN-g	GeneOrGeneProduct	15978
27630165	64	69	IL-10	GeneOrGeneProduct	16153
27630165	94	99	IL-10	GeneOrGeneProduct	16153
27630165	168	185	Malaria Infection	DiseaseOrPhenotypicFeature	D008288
27630165	187	190	CD4	GeneOrGeneProduct	12504
27630165	215	220	IFN-g	GeneOrGeneProduct	15978
27630165	255	260	IL-10	GeneOrGeneProduct	16153
27630165	276	285	infection	DiseaseOrPhenotypicFeature	D007239
27630165	368	371	CD4	GeneOrGeneProduct	12504
27630165	374	379	IFN-g	GeneOrGeneProduct	15978
27630165	382	387	IL-10	GeneOrGeneProduct	16153
27630165	430	439	infection	DiseaseOrPhenotypicFeature	D007239
27630165	565	570	IFN-g	GeneOrGeneProduct	15978
27630165	608	613	IL-10	GeneOrGeneProduct	16153
27630165	632	636	mice	OrganismTaxon	10090
27630165	659	676	malaria infection	DiseaseOrPhenotypicFeature	D008288
27630165	685	688	CD4	GeneOrGeneProduct	12504
27630165	765	770	IL-10	GeneOrGeneProduct	16153
27630165	828	831	CD4	GeneOrGeneProduct	12504
27630165	904	907	CD4	GeneOrGeneProduct	12504
27630165	1062	1066	PD-1	GeneOrGeneProduct	18566
27630165	1068	1073	Lag-3	GeneOrGeneProduct	16768
27630165	1079	1084	TIGIT	GeneOrGeneProduct	100043314
27630165	1149	1152	CD4	GeneOrGeneProduct	12504
27630165	1269	1278	infection	DiseaseOrPhenotypicFeature	D007239
27630165	1293	1296	CD4	GeneOrGeneProduct	12504
27630165	1366	1371	IL-10	GeneOrGeneProduct	16153
27630165	1400	1409	infection	DiseaseOrPhenotypicFeature	D007239
27630165	1428	1431	CD4	GeneOrGeneProduct	12504
27630165	1504	1509	IL-10	GeneOrGeneProduct	16153
27630165	1555	1572	malaria infection	DiseaseOrPhenotypicFeature	D008288
27630165	1583	1588	IL-10	GeneOrGeneProduct	16153
27630165	1654	1657	CD4	GeneOrGeneProduct	12504
27630165	1820	1825	IL-10	GeneOrGeneProduct	16153
27630165	1836	1839	CD4	GeneOrGeneProduct	12504
27630165	1896	1901	IL-10	GeneOrGeneProduct	16153
27630165	2007	2025	malaria infections	DiseaseOrPhenotypicFeature	D008288
27630165	Association	15978	D008288	No
27630165	Association	15978	100043314	Novel
27630165	Association	15978	16768	Novel
27630165	Association	15978	18566	Novel
27630165	Association	16153	D008288	No
27630165	Association	16153	100043314	Novel
27630165	Association	16153	16768	Novel
27630165	Association	16153	18566	Novel
27630165	Association	12504	D008288	No
27630165	Association	12504	100043314	Novel
27630165	Association	12504	16768	Novel
27630165	Association	12504	18566	Novel
27630165	Association	12504	15978	No
27630165	Association	12504	16153	No